Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection

AIDS

Volumn 25, Issue 4, 2011, Pages 525-529

  Szep, Zsofia ^a,b,c   Guaraldi, Giovanni ^d   Shah, Samir S ^a,c   Lo Re, Vincent ^a,b,c   Ratcliffe, Sarah J ^a,c   Orlando, Gabriella ^d   Carli, Federica ^d   Rossi, Rosario ^d   Rochira, Vincenzo ^d   Tebas, Pablo ^b  

^a Center for Clinical Epidemiology and Biostatistics   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

insulin resistance; metabolic syndrome; type 2 diabetes mellitus; vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; GLUCOSE;

ADULT; CARDIOVASCULAR RISK; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HIV INFECTIONS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79951516278     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328342fdfd     Document Type: Conference Paper

References (26)

1. De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, et al. Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care 2008; 31:1224-1229.
2. Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitz J, et al. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study. AIDS 2007; 21:1739-1745. (Pubitemid 47237561)
3. Koster JC, Remedi MS, Qiu H, Nichols CG, Hruz PW. HIV protease inhibitors acutely impair glucose-stimulated insulin release. Diabetes 2003; 52:1695-1700. (Pubitemid 36792459)
4. Brown TT, Li X, Cole SR, Kingsley LA, Palella FJ, Riddler SA, et al. Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study. AIDS 2005; 19:1375-1383. (Pubitemid 41800673)
5. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92:2017-2029. (Pubitemid 46997093)
6. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79:820-825. (Pubitemid 41103882)
7. Mattila C, Knekt P, Mannisto S, Rissanen H, Laaksonen MA, Montonen J, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 2007; 30:2569-2570. (Pubitemid 47547796)
8. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006; 29:650-656. (Pubitemid 44115368)
9. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005; 28:1228-1230. (Pubitemid 40616645)
10. Stephensen CB, Marquis GS, Kruzich LA, Douglas SD, Aldro-vandi GM, Wilson CM. Vitamin D status in adolescents and young adults with HIV infection. Am J Clin Nutr 2006; 83:1135-1141. (Pubitemid 44713115)
11. Garcia Aparicio AM, Munoz Fernandez S, Gonzalez J, Arribas JR, Pena JM, Vazquez JJ, et al. Abnormalities in the bone mineral metabolism in HIV-infected patients. Clin Rheumatol 2006; 25:537-539. (Pubitemid 44137629)
12. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, Sweep FC, Hermus AR, Bosch ME, et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008; 24:1375-1382.
13. Lattuada E, Lanzafame M, Zoppini G, Concia E, Vento S. No influence of nevirapine on vitamin D deficiency in HIV-in-fected patients. AIDS Res Hum Retroviruses 2009; 25:849-850.
14. Rodriguez M, Daniels B, Gunawardene S, Robbins GK. High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses 2009; 25:9-14.
15. Wasserman P, Rubin DS. Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIV-infected men under care. AIDS Patient Care STDS 2010; 24:223-227.
16. Bang UC, Shakar SA, Hitz MF, Jespersen MS, Andersen O, Nielsen SD, et al. Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study. Scand J Infect Dis 2010; 42:306-310.
17. Guaraldi G, Orlando G, Squillace N, De Santis G, Pedone A, Spaggiari A, et al. Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipo-dystrophy. HIV Clin Trials 2006; 7:97-106. (Pubitemid 44309000)
18. American Diabetes A. Standards of medical care in diabetes: 2008. Diabetes Care 2008; 31 (Suppl 1):S12-S54.
19. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. American Heart Association. National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [erratum appears in Circulation 2005; 112(17):e297]. Circulation 2005; 112:2735-2752. (Pubitemid 41532612)
20. Holick MF. Vitamin D deficiency [see comment]. N Engl J Med 2007; 357:266-281.
21. Cigolini M, Miconi V, Soffiati G, Fortanato A, Iagulli MP, Lombardi S, et al. Hypovitaminosis D among unselected medical inpatients and outpatients in Northern Italy. Clin Endocrinol (Oxf) 2006; 64:475.
22. Villamor E. A potential role for vitamin D on HIV infection? Nutr Rev 2006; 64:226-233. (Pubitemid 43953286)
23. Cozzolino M, Vidal M, Arcidiacono MV, Tebas P, Yarasheski KE, Dusso AS. HIV-protease inhibitors impair vitamin D bioac-tivation to 1,25-dihydroxyvitamin D. AIDS 2003; 17:513-520. (Pubitemid 36293104)
24. Michos ED, Melamed ML. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 2008; 11:7-12. (Pubitemid 350295219)
25. Zitterman A, Firsch S, Berthold HK, Gottin C, Kuhn J, Kleesiek K, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009; 89:1321-1327.
26. van den Bout-van den Beukel CJ, Van den Bos M, Oyen WJ, Hermus AR, Sweep FC, Tack CJ, et al. The effect of cholecalci-ferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D deficient HIV-1-infected patients. HIV Med 2008; 9:771-779.